Diplo shares a thirst trap photo from his vacation in Mexico - Lainey Gossip
Justin Bieber reveals his battle with Lyme disease - Teen Vogue
Diplo shares a thirst trap photo from his vacation in Mexico - Lainey Gossip
Justin Bieber reveals his battle with Lyme disease - Teen Vogue
Hamilton tested positive on Monday after experiencing "mild" symptoms. No replacement driver has been announced.
The "Speaker Driver Market With COVID-19 Impact by Device Type (Headphones/Earphones, Mobile Phones/Tablets, Smart Speakers), Driver Type (Dynamic Driver, Balanced Armature Driver), Size, Application, and Geography - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The latest ONS figures reveal at least 2,361 deaths were caused by coronavirus compared to just 280 from flu or pneumonia.
Evha Jannath, aged 11, died after she was ‘jolted’ out of a boat on the Splash Canyon ride in 2017.
The "PlayStation 5 and Xbox Series X/Xbox Series S: Analysis & Forecasts" report has been added to ResearchAndMarkets.com's offering.
International Olympic Committee President Thomas Bach is set to remain in office until 2025 as he will run unopposed next year for a second term, the IOC said on Tuesday. Bach succeeded outgoing president Jacques Rogge in 2013 after prevailing over five other candidates in an election in Buenos Aires. "The members of the IOC were informed today... that President Thomas Bach will be the only candidate for the presidential election, which will be held during the 137th IOC Session in Athens in March 2021," it said in a statement.
HC3, a data-driven technology company delivering unique customer communications, announces new roles for Lee Long as Chief Experience Officer, Lakyn Gaddy as Client Success Manager, and Kathy Taylor as Director of Strategic Partnerships. The trio joins HC3 after the company’s acquisition of Banc Statements. Inc. (BSI) in October 2020.
Vance Street Capital LLC ("Vance Street") is pleased to announce it has completed the sale of A&E Medical Corporation ("A&E Medical") to Zimmer Biomet (NYSE: ZBH) ("Zimmer"), a global leader in musculoskeletal healthcare, for $250 million. The transaction marks the second exit out of Vance Street’s Sophomore Fund.
The 39-year-old dancer said while the BLM movement had sparked conversation, it was important to continue it long-term.
The ruling has been described by charity Mermaids as a "devastating blow" to trans young people.
A global leader in dispute management and mitigation, Chargebacks911, today announced the appointment of Jia Min Tan to the role of Director of Business Development, APAC, as part of its ongoing expansion in the region.
Dublin, Dec. 01, 2020 (GLOBE NEWSWIRE) -- The "Needle Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030" report has been added to ResearchAndMarkets.com's offering. This report on the global needle biopsy market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period, 2020 to 2030 The report provides the overall Value (US$ Mn) and volume (units) of the global needle biopsy market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global needle biopsy market for the forecast period.The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global needle biopsy market.Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global needle biopsy market.The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on changing competitive dynamics in the global needle biopsy market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global needle biopsy market. The next section of the global needle biopsy market report highlights the USPs, which include breast cancer epidemiology, prostate cancer epidemiology, regulations related to premarket approval for new medical devices, regulations related to CE mark approval for new medical devices, overview of image guided needle biopsy, and impact of COVID-19 on the global needle biopsy market.The report delves into the competition landscape of the global needle biopsy market. Key players operating in the global needle biopsy market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global needle biopsy market report.Key Questions Answered in Needle Biopsy Market Report What is the sales/revenue generated by the global needle biopsy market across all the regions during the forecast period?What is the volume of biopsy needles across all the regions during the forecast period?What are the key trends in the global needle biopsy market?What are the major drivers, restraints, and opportunities in the global market?Which region is set to expand at the fastest CAGR during the forecast period?Which segment will have the highest revenue globally in 2030 and which biopsy needle will expand at the fastest CAGR during the forecast period? Needle Biopsy Market - Research Objectives and Research ApproachThe comprehensive report on the global needle biopsy market begins with an overview of the market, followed by scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global needle biopsy market. It is followed by market introduction, market dynamics, and an overview of the global needle biopsy market, which include analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the needle biopsy market. The next section of the global needle biopsy market report highlights the USPs, which include epidemiology of breast cancer epidemiology, prostate cancer epidemiology, regulations related to premarket approval for new medical devices, regulations related to CE mark approval for new medical devices, overview of image guided needle biopsy, and impact of COVID-19 on the global needle biopsy market.For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.Revenue generated by key biopsy needle manufacturers has been mapped to ascertain the size of the global needle biopsy market in terms of value. The forecast presented here assesses the total revenue generated in the needle biopsy market. In order to provide an accurate forecast, we initiated by sizing up the current needle biopsy market with the help of the parent market. Prices of different biopsy needles and number of biopsy procedures across different regions have been taken into consideration to drive the volume of biopsy needles during the forecast period.The report analyzes the global needle biopsy market in terms of type, application, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global needle biopsy market. Key Topics Covered: 1. Preface1.1. Market Definition and Scope1.2. Market Segmentation1.3. Key Research Objectives1.4. Research Highlights2. Assumptions and Research Methodology3. Executive Summary: Global Needle Biopsy Market4. Market Overview4.1. Introduction4.2. Overview4.3. Market Dynamics4.4. Global Needle Biopsy Market Analysis and Forecast, 2018-20305. Key Insights5.1. Disease Prevalence & Incidence Rate Globally with Key Countries5.2. Overview of the Image Guided Needle Biopsy5.3. Regulatory Scenario by Region/Globally5.4. COVID-19 Pandemics Impact on Global Needle Biopsy Market6. Global Needle Biopsy Market Analysis and Forecast, by Type6.1. Introduction & Definition6.2. Key Findings/Developments6.3. Needle Biopsy Market Value & Volume Forecast, by Type, 2018-20306.4. Market Attractiveness Analysis, by Type7. Global Needle Biopsy Market Analysis and Forecast, by Application7.1. Introduction & Definition7.2. Key Findings/Developments7.3. Needle Biopsy Market Value Forecast, by Application, 2018-20307.4. Market Attractiveness Analysis, by Application8. Global Needle Biopsy Market Analysis and Forecast, by End-User8.1. Introduction & Definition8.2. Key Findings/Developments8.3. Needle Biopsy Market Value Forecast, by End-User, 2018-20308.4. Market Attractiveness Analysis, by End-User9. Global Needle Biopsy Market Analysis and Forecast, by Region9.1. Key Findings9.2. Needle Biopsy Market Value Forecast, by Region9.3. Market Attractiveness Analysis, by Region10. North America Needle Biopsy Market Analysis and Forecast10.1. Introduction10.2. North America Needle Biopsy Market Value & Volume Forecast, by Type, 2018-203010.3. North America Needle Biopsy Market Value Forecast, by Application, 2018-203010.4. North America Needle Biopsy Market Value Forecast, by End-User, 2018-203010.5. North America Needle Biopsy Market Value Forecast, by Country, 2018-203010.6. North America Needle Biopsy Market Attractiveness Analysis11. Europe Needle Biopsy Market Analysis and Forecast11.1. Introduction11.2. Europe Needle Biopsy Market Value & Volume Forecast, by Type, 2018-203011.3. Europe Needle Biopsy Market Value & Volume Forecast, by Application, 2018-203011.4. Europe Needle Biopsy Market Value Forecast, by End-User, 2018-203011.5. Europe Needle Biopsy Market Value Forecast, by Country/Sub-Region, 2018-203011.6. Europe Needle Biopsy Market Attractiveness Analysis12. Asia-Pacific Needle Biopsy Market Analysis and Forecast12.1. Introduction12.2. Asia-Pacific Needle Biopsy Market Value & Volume Forecast, by Type, 2018-203012.3. Asia-Pacific Needle Biopsy Market Value Forecast, by Application, 2018-203012.4. Asia-Pacific Needle Biopsy Market Value Forecast, by End-User, 2018-203012.5. Asia-Pacific Needle Biopsy Market Value Forecast, by Country/Sub-Region, 2018-203012.6. Asia-Pacific Needle Biopsy Market Attractiveness Analysis13. Latin America Needle Biopsy Market Analysis and Forecast13.1. Introduction13.2. Latin America Needle Biopsy Market Value & Volume Forecast, by Type, 2018-203013.3. Latin America Needle Biopsy Market Value Forecast, by Application, 2018-203013.4. Latin America Needle Biopsy Market Value Forecast, by End-User, 2018-203013.5. Latin America Needle Biopsy Market Value Forecast, by Country/Sub-Region, 2018-203013.6. Latin America Needle Biopsy Market Attractiveness Analysis14. Middle East & Africa Needle Biopsy Market Analysis and Forecast14.1. Introduction14.2. Middle East & Africa Needle Biopsy Market Value & Volume Forecast, by Type, 2018-203014.3. Middle East & Africa Needle Biopsy Market Value Forecast, by Application, 2018-203014.4. Middle East & Africa Needle Biopsy Market Value Forecast, by End-User, 2018-203014.5. Middle East & Africa Needle Biopsy Market Value Forecast, by Country/Sub-Region, 2018-203014.6. Middle East & Africa Needle Biopsy Market Attractiveness Analysis15. Competitive Landscape15.1. Market Player - Competition Matrix (By Tier and Size of Companies)15.2. Company Share Analysis15.3. Company Profiles Companies Mentioned Hologic, Inc.C. R. Bard, Inc. (Becton, Dickinson and Company).INRAD, Inc.Argon MedicalCONMED CorporationOlympus CorporationStryker CorporationMedtronic plcMerit Medical Systems, Inc. For more information about this report visit https://www.researchandmarkets.com/r/ezdi2i Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The increases come in from January 1, with a 2nd class stamp rising by a penny to 66p.
The "Aircraft Cabin Interiors - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
The "Global Physical Intellectual Property Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
Veterinary Anesthesia Equipment Market Research Report by Product (Accessories, Complete Anesthesia Machines, Gas Delivery Management Systems, Vaporizers, and Ventilators), by Animal Type (Large and Small), by End-Use - Global Forecast to 2025 - Cumulative Impact of COVID-19New York, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Veterinary Anesthesia Equipment Market Research Report by Product, by Animal Type, by End-Use - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05993426/?utm_source=GNW The Global Veterinary Anesthesia Equipment Market is expected to grow from USD 912.67 Million in 2019 to USD 1,383.28 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.17%.Market Segmentation & Coverage:This research report categorizes the Veterinary Anesthesia Equipment to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Product, the Veterinary Anesthesia Equipment Market studied across Accessories, Complete Anesthesia Machines, Gas Delivery Management Systems, Vaporizers, Ventilators, and Waste Gas Management Systems. Based on Animal Type , the Veterinary Anesthesia Equipment Market studied across Large and Small. Based on End-Use, the Veterinary Anesthesia Equipment Market studied across Emergency service centers, Hospitals & Clinics, and Veterinary homecare settings. Based on Geography, the Veterinary Anesthesia Equipment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Anesthesia Equipment Market including A.M. Bickford, Inc., Burtons Medical Equipment Ltd, Dispomed ltd, DRE Veterinary, Everest Veterinary Technology, Hallowell Engineering & Manufacturing, Henry Schein, Inc., JD Medical, Kent Scientific Corporation, Medical Developments International Limited, Mediquip Pty Ltd, Miden Medical, Midmark Corporation, Mindray Medical International, Patterson Companies, Inc., Rothacher-Medical GmbH, RWD Life Science, Smiths Medical, Inc., Soar Medical Tech, Supera Anesthesia Innovations, Vetland Medical Sales & Services, LLC, and Zhong Ke Base Medical Technology. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Anesthesia Equipment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Veterinary Anesthesia Equipment Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Anesthesia Equipment Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Anesthesia Equipment Market?4. What is the competitive strategic window for opportunities in the Global Veterinary Anesthesia Equipment Market?5. What are the technology trends and regulatory frameworks in the Global Veterinary Anesthesia Equipment Market?6. What are the modes and strategic moves considered suitable for entering the Global Veterinary Anesthesia Equipment Market?Read the full report: https://www.reportlinker.com/p05993426/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Is it even a ‘DWTS’ season without Sharna?From Redbook
Germany's energy regulator on Tuesday said some 4,788 megawatts (MW) of hard coal-fired power generation capacity will cease to be marketable from Jan. 1, 2021 as part of a policy to take carbon-polluting capacity out of the market. The move reflects Germany's commitment to ending the fossil fuels age, idling the equivalent of five nuclear plants in one go, while cushioning the impact on utilities, regions and employment. Germany has decided to abandon coal by 2038 and achieve a mostly carbon-free energy system by 2050.
December 1, 2020 Dear Shareholders and Investors, The question of Covid-19 is often in focus. We addressed this in the first quarter of 2020, informing you that we did not see important implications for NAT from the Covid virus. We noted in our messages to you that the future of the tanker market to a large extent is dependent upon the Far East, where economic growth is sound. We are upholding this view. For us it is a question of transportation distance (ton miles), not necessarily the volume of oil itself. We see every day the strong push we have from the Far East. This is encouraging. Secondly, we assure you that NAT will continue to be a dividend company. We have paid dividend every quarter since the first NAT vessels were delivered to us in 1997. We shall continue on this path. While recognizing that dividend is a reflection of our earnings, we are optimistic on the future of the tanker market and the impact on NAT. Thirdly, already in October 2017 we informed you that the so called scrubber (Exhaust gas cleaning) installation is outside the scope of our activity. We did not wish to go for scrubbers above all because our philosophy is always to reduce risk to the maximum extent. We now observe that scrubbers may be banned in several parts of the world. We use fully compliant fuel on the engines of our vessels. Our objective is always to inform you as precisely as we can. Best wishes for this day, December 1, 2020, when we are approaching Christmas. Best regards, Herbjorn Hansson Founder, Chairman & CEO Nordic American Tankers Ltd. www.nat.bm CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “plan,” “potential,” “will,” “may,” “should,” “expect,” “pending” and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand in the tanker market, as a result of changes in OPEC’s petroleum production levels and worldwide oil consumption and storage, changes in our operating expenses, including bunker prices, drydocking and insurance costs, the market for our vessels, availability of financing and refinancing, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessels breakdowns and instances of off-hires and other important factors described from time to time in the reports filed by the Company with the Securities and Exchange Commission, including the prospectus and related prospectus supplement, our Annual Report on Form 20-F, and our reports on Form 6-K. NAT is a Bermuda based company. Contacts: Gary J. WolfeSeward & Kissel LLPNew York, USATel: +1 212 574 1223 Bjørn Giæver, CFONordic American Tankers LimitedTel: +1 888 755 8391 or +47 91 35 00 91 Herbjørn Hansson, Chairman & CEONordic American Tankers LimitedTel: +1 866 805 9504 or +47 90 14 62 91
CRESCO LABS LAUNCHES EIGHTH CANNABIS BRAND, WONDER WELLNESS CO.